| 000 | 01611 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516054313.0 | ||
| 264 | 0 | _c20120117 | |
| 008 | 201201s 0 0 eng d | ||
| 022 | _a1536-4844 | ||
| 024 | 7 |
_a10.1002/ibd.21612 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRiello, Laura | |
| 245 | 0 | 0 |
_aTolerance and efficacy of azathioprine in pediatric Crohn's disease. _h[electronic resource] |
| 260 |
_bInflammatory bowel diseases _cOct 2011 |
||
| 300 |
_a2138-43 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAzathioprine _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aCrohn Disease _xdrug therapy |
| 650 | 0 | 4 | _aEnteral Nutrition |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMaximum Tolerated Dose |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aTalbotec, Cécile | |
| 700 | 1 | _aGarnier-Lengliné, Hélène | |
| 700 | 1 | _aPigneur, Bénédicte | |
| 700 | 1 | _aSvahn, Johan | |
| 700 | 1 | _aCanioni, Danielle | |
| 700 | 1 | _aGoulet, Olivier | |
| 700 | 1 | _aSchmitz, Jacques | |
| 700 | 1 | _aRuemmele, Frank M | |
| 773 | 0 |
_tInflammatory bowel diseases _gvol. 17 _gno. 10 _gp. 2138-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ibd.21612 _zAvailable from publisher's website |
| 999 |
_c21150029 _d21150029 |
||